Brian Madden
Marvell Technology Group
MRVL-Q
DON'T BUY
Feb 21, 2023
A high-beta 1.5 stock. Not a pretty chart nor is it cheap at 20x PE. As the market goes, so goes this stock. No sign of an upturn. Exposure to China is double their peers which is a concern, so semis are being more and more restricted by governments, so that's a risk. Compounded returns over 5 years have been 14% annually, which beats the market, but AMD and others are double.
Is in the middle of an historic decline, despite its earnings having an historic advance. It's been punished enough. Buy a quarter position here and another at $50. The CEO bought a ton of stock.
A year ago, everyone was trying to find the next best thing to NVDA. System-on-a-chip puts chips out closer to the data, a nice niche. 12-month price target of $112.50, great runway.
Semiconductors, broadly, have become like shooting fish in a barrel since ChapGPT made its debut in late 2022. All are pretty cyclical. Likes others better, such as NVDA and AVGO.
Interesting company. Big issue on semi demand is really the Chip Act, how it applies to China, and what it does to demand for everyone else. China will be looking to increase market share. You want bigger and better, so he'd probably rather own AVGO.
He targets $108. They just beat top and bottom lines and raised guidance. They delivered record Q1 revenue, a 63% pop YOY. Are running on all cylinders. Strong momentum.
Doesn't own because of the cyclical industry. If you get the timing right, can do very well. He likes companies with an economic moat such as TSM, and he's considering ASML.
System-on-a-chip architecture is very attractive to Edge AI. Memory business makes it a bit of a cyclical stock. 12-month price target of $90.50. The tech arena may not be frothy, but it isn't cheap, and this one is good value.
A high-beta 1.5 stock. Not a pretty chart nor is it cheap at 20x PE. As the market goes, so goes this stock. No sign of an upturn. Exposure to China is double their peers which is a concern, so semis are being more and more restricted by governments, so that's a risk. Compounded returns over 5 years have been 14% annually, which beats the market, but AMD and others are double.